Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypes. - Wikidata - wikimedia - TriplyDB

Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypes.

Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypes.

http://www.wikidata.org/entity/Q36035812

about

Gene Expression Differences in Prostate Cancers between Young and Old Men Prognostic outlier genes for enhanced prostate cancer treatment.Molecular classification of prostate adenocarcinoma by the integrated somatic mutation profiles and molecular network The Molecular Taxonomy of Primary Prostate Cancer.Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 Patients.Toward Precision Medicine: A Cancer Molecular Subtyping Nano-Strategy for RNA Biomarkers in Tumor and Urine.Translational and clinical implications of the genetic landscape of prostate cancer.Dual tumor suppressing and promoting function of Notch1 signaling in human prostate cancer.DESNT: A Poor Prognosis Category of Human Prostate Cancer.Molecular biomarkers to guide precision medicine in localized prostate cancer.ERG expression in prostate cancer: biological relevance and clinical implication.MNX1 Is Oncogenically Upregulated in African-American Prostate Cancer.Molecular subtyping of prostate cancer.Somatic molecular subtyping of prostate tumors from HOXB13 G84E carriers.Clinical and molecular rationale to retain the cancer descriptor for Gleason score 6 disease.Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis.PARP Inhibitors in Prostate Cancer.Prognostic Utility of a New mRNA Expression Signature of Gleason Score.Genomic testing for localized prostate cancer: where do we go from here?Intratumoral and Intertumoral Genomic Heterogeneity of Multifocal Localized Prostate Cancer Impacts Molecular Classifications and Genomic Prognosticators.Integrated Classification of Prostate Cancer Reveals a Novel Luminal Subtype with Poor Outcome.Application of a Clinical Whole-Transcriptome Assay for Staging and Prognosis of Prostate Cancer Diagnosed in Needle Core Biopsy Specimens Racial Variations in Prostate Cancer Molecular Subtypes and Androgen Receptor Signaling Reflect Anatomic Tumor Location The expression profile and prognostic value of SPINK1 in initially diagnosed bone metastatic prostate cancer.The association between SPINK1 and clinical outcomes in patients with prostate cancer: a systematic review and meta-analysis.Low PCA3 expression is a marker of poor differentiation in localized prostate tumors: exploratory analysis from 12,076 patients.Clonal evaluation of prostate cancer foci in biopsies with discontinuous tumor involvement by dual ERG/SPINK1 immunohistochemistry.Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy.High levels of 5-hydroxymethylcytosine (5hmC) is an adverse predictor of biochemical recurrence after prostatectomy in ERG-negative prostate cancer RGS12 Is a Novel Tumor-Suppressor Gene in African American Prostate Cancer That Represses AKT and MNX1 Expression.Ethnicity and ERG frequency in prostate cancer.IDH1R132H Promotes Malignant Transformation of Benign Prostatic Epithelium by Dysregulating MicroRNAs: Involvement of IGF1R-AKT/STAT3 Signaling Pathway.Prostatic cancers: understanding their molecular pathology and the 2016 WHO classification.Exogenous IL6 induces mRNA splice variant MBD2_v2 to promote stemness in TP53 wild-type, African American PCa cells.Comprehensive Determination of Prostate Tumor ETS Gene Status in Clinical Samples Using the CLIA Decipher Assay.Chemotherapy and radiation for prostate cancer

P2860

Q28468529-626E41E6-4515-4FD1-BC97-EB3D2E77C3AB Q30244674-944D5837-B7AA-4DB8-BEEE-89CAD4C8D77E Q33677773-3562C5B3-9917-4345-9222-B30EF709E765 Q34674332-9ECEF2A4-A11F-4316-9CEB-96ABFC9EE92D Q35690915-E6162A9A-10EE-46A8-A650-EA9E3C74FC1B Q36157852-DAE670BB-28C3-4FE2-8C5D-2AB9C21B610C Q37270512-68813AD6-02C4-4580-9691-E3A622A021B3 Q37565364-E867FB9F-2737-46D1-90EB-547CC9937D34 Q38655020-D7E6857A-96A1-4BD5-94F6-5B50B2EACDB8 Q38668635-EC5CDB27-1795-4C7B-AFCD-265AE2F861AA Q38681610-3A3269A4-2402-4EB3-85BB-CF947139A6B5 Q38734374-1736BBEE-0F8F-4B14-ADEE-C9D214173D89 Q38778266-67FE2F6E-4E72-4F42-B480-049A5C5B8670 Q38967389-ADED79C9-FD54-4D2C-BA35-532C7751123E Q39023426-8D52D176-255B-4D6F-8947-1291C06F22B9 Q39227619-5ACD3B07-5728-4318-8E64-027059FD9655 Q39328164-E570B7AC-D4FA-48D3-AF71-4B1DC653CC87 Q39356307-D654521F-B0E5-4C4C-98D5-B4313859563A Q39404903-2779903C-F183-4EA2-B0A1-D2116AE40A77 Q39566728-EBE8899F-D222-4239-80F3-7CE856432393 Q39683347-6FF43567-E93E-4451-876E-ED4E599E3B51 Q39946238-258F52B4-28BF-4008-814B-0B61910E4490 Q40006369-4007A958-9608-4C40-A291-E31CCA60EE67 Q40763465-F4DB8777-6802-4671-AF88-244FADC5097D Q41016093-1157DD5D-9DF5-4C66-AA59-AD7D844C9CA8 Q41612462-62D0E90E-AD7E-46F8-917E-FFABD5B02EFD Q42120206-546E745B-2ACD-4178-83B3-A2F35B79281A Q42509592-2F162C3D-36AF-4447-9071-8F69F1ECDACB Q42539779-5933FDB7-0C9D-4AFB-BB0C-CBA7E965D997 Q46160241-1ADAC23C-BBDB-4108-8F3F-75E53B08502E Q46504038-8672D310-2A0B-49BB-B48F-816CA147906B Q49329227-91687F9E-7309-4E7F-84FF-DA23A39C8E40 Q52629153-9F514378-DCFA-4724-A015-7648E3A8EE91 Q53684369-BA047CCE-2779-468E-9694-47D174EE029D Q54474207-CC288A34-0FD5-4121-A61B-37EFB3E23FC2 Q57112428-F9012124-1078-4D60-A926-E934CCE303C7

P2860

Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypes.

http://www.wikidata.org/entity/Q36035812

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Characterization of 1577 prima ...... ights into molecular subtypes.

@ast

Characterization of 1577 prima ...... ights into molecular subtypes.

@en

type

label

Characterization of 1577 prima ...... ights into molecular subtypes.

@ast

Characterization of 1577 prima ...... ights into molecular subtypes.

@en

prefLabel

Characterization of 1577 prima ...... ights into molecular subtypes.

@ast

Characterization of 1577 prima ...... ights into molecular subtypes.

@en

P1433

Q36035812-47A16312-9E64-47E7-89F3-FCE16622E931

P1476

Q36035812-314638E8-78B1-4BBD-846B-F271CBDEFA69

P2093

Q36035812-3865F23D-9008-4A21-ADE1-A5D686DE63CD

Q36035812-7B877BDB-0C4C-47A6-A54C-22C0A302F37C

Q36035812-8CC99501-CCD1-4038-9312-42F47ADB1D83

Q36035812-D4AE86DB-5FAB-4C01-8060-054606564848

Q36035812-E7499D35-2581-4F41-B70D-FAE18A1AD941

Q36035812-FA03D909-C510-47F6-8F8E-AA2780E6CB1D

Q36035812-FDE50843-FC57-49BE-8F71-7E0108C92058

P2860

Q36035812-07745D26-5490-44CD-B998-233819E4B1E3

Q36035812-07766F1B-3E0A-4852-BECA-461CFCC815F3

Q36035812-08E9DF05-EE71-4F40-B05A-79143DEBDFAD

Q36035812-08EEDA51-A2D8-4B46-A663-C3B5EEC2AA74

Q36035812-11A554D3-F210-48E2-88E1-7AE8F63E94B5

Q36035812-1BB98170-CC5C-4611-84DB-F8C001B4D2CC

Q36035812-21B9E52D-FC86-4CBF-B201-2532B12931BE

Q36035812-2484764C-EA2F-48BF-8CE6-488B74DC0933

Q36035812-2BF7F67A-EC11-4157-9ECB-4C50158783C3

Q36035812-2C8AF127-8454-45C2-A354-4F508C7526C9

P304

Q36035812-02853366-3BD3-4E20-A22F-47F58A051755

P31

Q36035812-2D09A22B-D8BD-49E0-BD6E-EEE0AF3F4953

P356

Q36035812-7760F1CB-9C65-4CC6-8627-4937CFA8064E

P407

Q36035812-18007DE6-D3DB-47F5-AD21-5C92ABE010D9

P433

Q36035812-692E5D35-273A-4CC5-A904-FC8E2DD1E295

P478

Q36035812-0E84EBC2-7D56-42B5-B596-A95BF35C3ABB

P50

Q36035812-032D09EE-A19B-44F2-9CB8-CBDE03361DCE

Q36035812-0B295021-A60B-4AAD-B95C-77B809A77A14

Q36035812-1F05B2FC-3C42-4FC9-9F37-3064BF2ED851

Q36035812-4AE9C572-85E0-4176-ABC4-DE686EE445D4

Q36035812-4E9BE634-3BE7-417E-9FBE-D13EC10C3E46

Q36035812-5E862562-3C46-416D-9833-C598CA6BDB7B

Q36035812-A674626D-7E61-4AFC-812F-600A9C22BF0A

Q36035812-BFDAAFCB-2260-4170-85C4-C06A16C3EA1B

Q36035812-D012F5F6-F682-4EA4-8841-DE83354D9218

Q36035812-E41904D8-C56F-4368-923E-87986B969DBE

P577

Q36035812-0220220C-6200-4133-9234-D5AC724FB0BD

P698

Q36035812-96BCFF02-FAC9-4300-9E70-757A00CEDFFA

P932

Q36035812-C3AADB7E-BBBF-4BA7-BDCA-0F7F7D0911CC

P356

J.EURURO.2015.04.033

P1433

European Urology

P1476

Characterization of 1577 prima ...... ights into molecular subtypes.

@en

P2093

Angelo M DeMarzo

http://www.w3.org/2001/XMLSchema#string

Cristina Magi-Galluzzi

http://www.w3.org/2001/XMLSchema#string

R Jeffrey Karnes

http://www.w3.org/2001/XMLSchema#string

Robert B Jenkins

http://www.w3.org/2001/XMLSchema#string

Scott A Tomlins

http://www.w3.org/2001/XMLSchema#string

Shuang Zhao

http://www.w3.org/2001/XMLSchema#string

Zaid Haddad

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer

The role of SPINK1 in ETS rearrangement-negative prostate cancers

Pooled analysis of the prognostic and predictive effects of KRAS mutation status and KRAS mutation subtype in early-stage resected non-small-cell lung cancer in four trials of adjuvant chemotherapy.

Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy

Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK

Integrative genomic profiling of human prostate cancer

Genomic prostate cancer classifier predicts biochemical failure and metastases in patients after postoperative radiation therapy

ERG induces taxane resistance in castration-resistant prostate cancer

TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signaling.

A tissue biomarker panel predicting systemic progression after PSA recurrence post-definitive prostate cancer therapy

P304

555-567

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EURURO.2015.04.033

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

68

http://www.w3.org/2001/XMLSchema#string

P50

Edward M Schaeffer

Mohammed Alshalalfa

P577

2015-05-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25964175

http://www.w3.org/2001/XMLSchema#string

P932

4562381

http://www.w3.org/2001/XMLSchema#string